Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole.

Saved in:
Bibliographic Details
Title: Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole.
Authors: Randell RL; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Balevic SJ; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Greenberg RG; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Cohen-Wolkowiez M; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Thompson EJ; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Venkatachalam S; Duke Clinical Research Institute, Durham, North Carolina, USA., Smith MJ; Department of Pediatrics, Duke University, Durham, North Carolina, USA., Bendel C; Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA., Bliss JM; Department of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA., Chaaban H; Division of Neonatology, Department of Pediatrics, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA., Chhabra R; Division of Neonatology, Department of Pediatrics, Hackensack University Medical Center, Hackensack, New Jersey, USA., Dammann CEL; Department of Pediatrics, Tufts Medical Center, Tufts University, Boston, Massachusetts, USA., Downey LC; Department of Pediatrics, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA., Hornik C; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA., Hussain N; Division of Neonatology, Department of Pediatrics, Connecticut Children's, Hartford, Connecticut, USA., Laughon MM; Department of Pediatrics, Division of Neonatal-Perinatal Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lavery A; Loma Linda University, Loma Linda, California, USA., Moya F; Division of Wilmington Pediatric Specialties, Department of Pediatrics, UNC School of Medicine, Chapel Hill, North Carolina, USA., Saxonhouse M; Division of Neonatology, Department of Pediatrics, Levine Children's Hospital, Wake Forest School of Medicine, Charlotte campus, Atrium Healthcare, Charlotte, North Carolina, USA., Sokol GM; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA., Trembath A; Division of Neonatal-Perinatal Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Weitkamp J-H; Mildred Stahlman Division of Neonatology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Hornik CP; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Durham, North Carolina, USA.
Corporate Authors: Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Apr 03; Vol. 68 (4), pp. e0153323. Date of Electronic Publication: 2024 Mar 14.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Validation Study
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-6596
DOI:10.1128/aac.01533-23